Document is current

Article History

Received: 31 July 2025

Accepted: 4 February 2026

First Online: 12 May 2026

Declarations

:

: This study was adhered to the standards of clinical practice and research regulations (Law of Biomedical Research 14/2007), in agreement with the Declaration of Helsinki and the Convention on Human Rights and Biomedicine. Compliance with the protection of non‐public personal data of all those involved within the RGPD–UE 2016/679, LOPDGDD 3/2018, Law 41/2002 and its implementing regulations, Royal Decree 1720/2007, was enforced. This project (PI20/00413), granted by Carlos III Health Institute (ISCIII; Spain), was supervised by the local ethics committee, the Research Ethical Committee of Galicia (code CEIm‐G 2018/609, Galicia, Spain), and by the Spanish Agency for Medicines and Healthcare Products (AEMPS) for the use of CRC patients’ samples from CHUAC (A Coruña, Galicia, Spain). Informed consent for Biobank (CHUAC, A Coruña, Galicia, Spain, UNE‐EN ISO 9001‐2015) was signed by all individuals grouped in this study. Anonymized clinical data used during the study for CRC patients was obtained from the Galician Health Service (SERGAS).

: All individuals recruited in this project (CRC and non‐CRC) signed a formal consent form for the publication of scientific and clinical results in scientific articles.

: The authors declare no competing interests.